by Marybeth Burke – Afatinib, an irreversible ErbB-family blocker, delays progression of advanced lung cancer in patients with epidermal growth factor receptor (EGFR) mutations compared with standard chemotherapy,
25 Feb 2012 – EAU Paris – Men often finds it difficult to talk with primary health specialists and this is certainly true in the case of BPH.
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
26 Feb 2012 – EAU Paris, France – What have been some of the EAU highlights to date? And what are some Key messages to share with Irish… read more.
Proactive BPH Discussion with Professor Mark Emberton from the EAU, Paris 2012
Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH),
As a man’s waistline grows, so can his experience with sexual dysfunction and frequent urination, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
As a man’s waistline grows, so can his experience with sexual dysfunction and frequent urination, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Vasectomy reversals should be carried out by urology specialists with access to appropriate micro-surgical training and assisted reproductive technologies and not general urology surgeons,
Interviews of Prof Mark Emberton and Dr Jan de Boer after their presentations at the EAU 2012 in Paris. They have unique insights about BPH and how to… read more.
Conclusions of the ICD for Life Summit held in Belgrade, Serbia “Implantable devices can save lives and decrease mortality, they are not a luxury”
Second study sheds light on the ‘obesity paradox’ People can be obese but metabolically healthy and fit, with no greater risk of developing or dying from cardiovascular disease… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
